To examine the biology of relapsed Acute Lymphoblastic Leukaemia (ALL) and improve its outcome using a combination of chemotherapy and nationally standardised approach to Haematopoietic Stem Cell Transplantation (HSCT).
International collaborative treatment protocol for infants under one year with acute lymphoblastic leukaemia
To improve the outcome for infants (under the age of 1) with acute lymphoblastic leukaemia (ALL) - a group of children with a very poor prognosis who have not so far benefited from the advances in treatment seen in other childhood leukaemias.